Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 18Venous Thromboembolism 16Venous Thrombosis 5Pulmonary Embolism 4Treatment of Venous Thromboembolism in Cancer Patients 3Thrombosis 3Multiple Myeloma 3Upper Extremity Deep Vein Thrombosis 2Lung Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Recurrence 1Prostatic Neoplasms 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Lymphoma 1Leukemia 1Inflammation 1Immune System Diseases 1Hemorrhage 1Hematologic Neoplasms 1

Interventions

apixaban 2Rivaroxaban 2Central Venous Catheters 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Upper Extremity Deep Vein Thrombosis × Rivaroxaban × Clear all
NCT03506815 2024-07-05

TRIM-Line

Ottawa Hospital Research Institute

Phase 3 Completed
105 enrolled 15 charts

Neoplasms, Upper Extremity Deep Vein Thrombosis

NCT01708850 2016-09-08

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

London Health Sciences Centre

Phase 4 Completed
70 enrolled

Neoplasms, Upper Extremity Deep Vein Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡